AEON Biopharma (AEON)

• Market cap: $18.9M
• 1 day: -2.74%
• 5 days: 2.77%
• 1 month: -4.09%
• 3 months: -27.31%
• 6 months: -33.4%
• Year to date: -35.2%
• 1 year: -5.36%
• 5 years: -99.9%
• 10 years: -99.9%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Employees: 8